Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mansi Arora

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancer Chemotherapy and Pharmacology|May 23, 2020
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancerMansi Arora, James M Bogenberger, Amro Abdelrahman, et al.
JCO Precision Oncology|June 6, 2022
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based ChemotherapyPedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancersBolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
Digestive Diseases and Sciences|November 13, 2021
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic AlterationsPedro Luiz Serrano Uson Junior, Thomas T DeLeon, James M Bogenberger, et al.
Hepatology (Baltimore, Md.)|August 18, 2021
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancersMansi Arora, James M Bogenberger, Amro M Abdelrahman, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancer Chemotherapy and Pharmacology|May 23, 2020
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancerMansi Arora, James M Bogenberger, Amro Abdelrahman, et al.
JCO Precision Oncology|June 6, 2022
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based ChemotherapyPedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancersBolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
Digestive Diseases and Sciences|November 13, 2021
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic AlterationsPedro Luiz Serrano Uson Junior, Thomas T DeLeon, James M Bogenberger, et al.
Hepatology (Baltimore, Md.)|August 18, 2021
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancersMansi Arora, James M Bogenberger, Amro M Abdelrahman, et al.
Pageof 4